Roska unit centers around healthcare

Share this article:
Roska Direct Advertising has restructured into three distinct units, including a rebranded healthcare advertising arm.

Roska Direct Advertising will focus on the consumer and business-to-business markets, while the Roska Healthcare Advertising unit will be specific to healthcare advertising, and Roska Digital Advertising will focus on digital marketing.

Roska veteran Jay Bolling has been selected to lead Roska Healthcare Advertising as its president. Bolling recently told MM&M that the new unit would undergo a “subtle” introduction to the industry under its new brand identity. The group's results, however, will be anything but subdued, he explained.

“What we are trying to do with Roska Healthcare Advertising is focus on a message that will be very similar to the overall message of Roska,” he said. 

In the past, the Roska healthcare unit has worked with clients including Pfizer, AstraZeneca, GlaxoSmithKline and Bristol-Myers Squibb.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...